What is more, a mechanistic study revealed that there were significant upregulations in the levels of IL-4, IL-10, and TGF-β, as well as markedly decreased levels of IFN-γ and IL-17 among T1D mice after the treatment with MSC-derived EVs (65). Here, IL17A is linked to type 1 diabetes mellitus.